Search Thermo Fisher Scientific
图: 1 / 2
This antibody is predicted to react with mouse and rat based on sequence homology.
This antibody is tested in Peptide ELISA: antibody detection limit dilution 32,000.
Ubiquitin-like molecules, such as SUMO1, are structurally related to ubiquitin. and can be ligated to target proteins in a similar manner as ubiquitin. However, covalent attachment of UBLs does not result in degradation of the modified proteins. SUMO1 modification is implicated in the targeting of RANGAP1. to the nuclear pore complex, as well as in stabilization of I-kappa-B-alpha from degradation by the 26S proteasome. Like ubiquitin, UBLs are synthesized as precursor proteins, with 1 or more amino acids following the C-terminal glycine-glycine residues of the mature UBL protein. Thus, the tail sequences of the UBL precursors need to be removed by UBL-specific proteases, such as SENP6, prior to their conjugation to target proteins. SENPs also display isopeptidase activity for deconjugation of SUMO-conjugated substrates.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: 2810017C20Rik; FLJ11355; FLJ11887; KIAA0389; RP1-134M13.1; Sentrin-specific protease 6; Sentrin/SUMO-specific protease SENP6; SUMO-1-specific protease 1; SUMO1/sentrin specific protease 6
基因别名: FKSG6; KIAA0797; SENP6; SSP1; SUSP1
UniProt ID: (Human) Q9GZR1
Entrez Gene ID: (Human) 26054